Tobramycin Solution
Product Images NDC 59651-129

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 59651-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Relative Change From Baseline In Fev1% Predicted (Tobramycin Fig1)

FDA Label Image

Figure H (Tobramycin Fig10)

FDA Label Image

Figure I (Tobramycin Fig11)

FDA Label Image

Figure J (Tobramycin Fig12)

FDA Label Image

Figure K (Tobramycin Fig13)

FDA Label Image

Figure L (Tobramycin Fig14)

FDA Label Image

Figure M (Tobramycin Fig15)

FDA Label Image

Figure N (Tobramycin Fig16)

FDA Label Image

Figure O (Tobramycin Fig17)

FDA Label Image

Figure P (Tobramycin Fig18)

FDA Label Image

Figure Q (Tobramycin Fig19)

FDA Label Image

Figure 2: Absolute Change From Baseline In Log10 Cfus (Tobramycin Fig2)

FDA Label Image

Package Label-principal Display Panel (300 mg per 5 mL)

FDA Label Image

Package Label-principal Display Panel (300 mg per 5 mL)

FDA Label Image

Figure A (Tobramycin Fig3)

FDA Label Image

Figure B (Tobramycin Fig4)

FDA Label Image

Figure C (Tobramycin Fig5)

FDA Label Image

Figure D (Tobramycin Fig6)

FDA Label Image

Figure E (Tobramycin Fig7)

FDA Label Image

Figure F (Tobramycin Fig8)

FDA Label Image

Figure G (Tobramycin Fig9)

FDA Label Image

Chemical Structure (Tobramycin Str)